Jeroen B. Van Beek - Nov 8, 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Chief Commercial Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Nov 8, 2022
Transactions value $
-$107,293
Form type
4
Date filed
11/10/2022, 04:29 PM
Previous filing
Oct 26, 2022
Next filing
Nov 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$2.39K -299 -0.07% $8.00 400K Nov 8, 2022 Direct F1
transaction ALVR Common Stock Sale -$105K -13.1K -3.28% $8.00 386K Nov 10, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 4, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.